Dabur OncQuest Receives NABL Accreditation

EHM News Bureau

Vivek Trikha, Head-Diagnostics, Dabur OncQuest

Dabur OncQuest, a pioneer in Indian oncology medical testing market, at the forefront of oncology research has recently been accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) in accordance with ISO 15189:2003, which is specific to medical testing laboratories. This accreditation is valid for the next two years and Dabur OncQuest is the only specialised oncology medical testing focus laboratory to receive this recognition. Also, OncQuest has been awarded this accreditation in the shortest time.

On receiving the accreditation, Vivek Trikha, Head-Diagnostics, Dabur OncQuest, said, "We are happy to receive this recognition from the sole authority on medical testing and calibration in India. This accreditation has given an impetus to our mission of extending the survival and improving the quality of life of cancer patients by providing scientifically-advanced, cost-effective molecular diagnostics tests."

OncQuest's new technologically advanced clinical and research laboratory is fully equipped with molecular technologies allowing for rapid advancement in the complex field of proteomics, genomics, and bioinformatics. OncQuest is one of its kind laboratory in South-East Asia to have exclusively ventured in the area of molecular diagnostics and other advanced medical testing techniques. The new integrated research facility provides a strong foundation for Dabur OncQuest to grow within the field of genetic oncology. This laboratory is equipped to provide the most advanced proteins/antibodies and nucleic acid-based diagnostic and prognostic tests for better and more accurate diagnosis and management of cancer.